Mahavir Advanced Remedies (Delisted) bulk deals and stake changes
BSE: 531689Pharmaceuticals & Biotechnology
Last traded ₹150.65 on 6 Jan 2015
Delisted on 23 Nov 2023.
Mahavir Advanced Remedies stake sales and purchases
All 3 disclosures on record.
Jun 2013
- SoldB Vijayalakshmi & PACs · promoter2.78% of the company3,15,600 shares13 Jun 2013 · filed under the 2% rule · Off-Market
- SoldBVS Kiran Kumar & PACs · promoter1.68% of the company1,90,650 sharesholds 0.96% after13 Jun 2013 · filed under the 2% rule · Off-Market
- SoldBVS. Koteeswara Rao & PACs · promoter2.68% of the company3,04,500 shares13 Jun 2013 · filed under the 2% rule · Off-Market
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Mahavir Advanced Remedies bulk deals
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Tuesday 2 Dec 20141 firm · ₹0 bought · ₹1.72 Cr soldNet sold ₹1.72 Cr
- SoldKIRAN KUMAR MSold 57,000 at ₹301.600.50% of the company₹1.72 Cr
A bulk deal is one client trading half a per cent or more of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. 1 deal on record from 4 Jan 2004.